Rate My Professor Max Berry

Berry's research centers on pre-clinical and clinical investigations into novel interventions to counteract the consequences of an altered perinatal environment on offspring cardiometabolic and neurodevelopmental outcomes. Her work bridges basic sciences and clinical advancements in perinatal care. Key publications include the PLUSS randomized clinical trial on intratracheal budesonide with surfactant for extremely preterm infants (JAMA, 2024), the UNICORN observational cohort study on creatine for neonatal neurological health (Journal of the International Society of Sports Nutrition, 2025), safety of maternal creatine supplementation in a guinea pig model (same journal, 2025), and diurnal timing of antenatal steroids on fetal lung maturation (Journal of Paediatrics & Child Health, 2025). Earlier contributions encompass gestational age impacts on adolescent health and education (Pediatrics, 2018) and docosahexaenoic acid supplementation for bronchopulmonary dysplasia prevention (NEJM, 2017). She has secured significant funding, including Neurological Foundation support ($180,120 in 2018) and Health Research Council grants. Her efforts advance understanding and mitigation of preterm birth's lifelong effects, shaping neonatal interventions.